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Abstract 
Inflammatory Fibroid Polyp (IFP) of gastrointestinal tract 
is characterized by concentric perivascular fibrosis and a 
mixed inflammatory infiltrate rich in eosinophils and also 
few plasma cells. IgG4-related sclerosing diseases (IgG4-
RSD) are a heterogenous group of disorders described 
in many organs, characterized by a significant increased 
of IgG4+ plasma cells in a context of storiform fibrosis, 
obliterative vasculitis and mixed inflammatory infiltrate 
containing eosinophils. The histological similarities 
between IFP and IgG4-RSD prompted the present study 
in the attempt to find a possible link between IgG4 over-
expression and IFP.
The expression of IgG4 and IgG was evaluated in 
a series of 23 cases of IFP belonging to 23 patients. 
All cases were reviewed by two pathologists and the 
histological diagnosis confirmed. Immunohistochemistry 
for antibodies anti-IgG, anti-IgG4, and anti-IgA was 
performed on all cases and the results were evaluated by 
two observers.
One case of IFP out of 23 (4.3%) fulfilled the IgG4-
RSD histological criteria. The case did not differ 
histologically from the others. The patient did not present 
either a raised serological level of IgG4, nor other sign of 
IgG4-RSD.
IgG4 increased expression can be rarely observed 
in IFP. Steroid therapy in cases of IFP with abundant 
IgG4+ plasma cells, especially in patients with multiple 
tumors, could be considered as an alternative to surgical 
treatment.
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INTRODUCTION
Inflammatory Fibroid Polyps (IFP) of gastrointestinal 
tract, firstly described by Vanek[1], is characterized 
by concentric perivascular fibrosis and a mixed 
inflammatory infiltrate rich in eosinophils and also few 
plasma cells. IFP can present as multiple tumors, and has 
been recently proposed as a neoplastic process, due to 
the discovery of activating mutations of PDGFRA gene 
in up to 66% of cases[2]. Despite this genetic similarity 
with gastrointestinal stromal tumors, the prognosis of IFP 
is always benign, and metastatic progression has never 
been reported in the literature [3]. IgG4-related sclerosing 
diseases (IgG4-RSD) are a heterogenous group of 
disorders described in many organs, characterized by a 
significant increased of IgG4+ plasma cells in a context 
of storiform fibrosis, obliterative vasculitis and mixed 
inflammatory infiltrate containing eosinophils[4]. The 
histological similarities observed between IFP and IgG4-
RSD prompted the present study. The expression of IgG4 
and IgG was evaluated in a series of IFP in the attempt 
to find a possible link between IgG4 over-expression and 
the development of the tumors, analogously to what has 
been observed for IgG4-related tumors arisen in other 
anatomical sites[5]. 
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MATERIALS AND METHODS
Twenty-three cases belonging to 23 patients were 
investigated. All cases were reviewed by two pathologists 
(LM and AMC) and the diagnosis confirmed. Clinico-
pathological data of the cases are listed in Table. 1. In 
patients with gastric lesions, Helicobacter Pylori was 
absent. Immunohistochemistry was performed by using 
the antibodies anti-IgG (polyclonal, Ventana, Ca, USA), 
anti-IgG4 (clone MRQ-44, Ventana), and anti-IgA 
(polyclonal, Ventana). Evaluation of immunohistochemical 
results was performed by two different observers (SL and 
AMC). Criteria of evaluation for IgG4-RSD were: >50 
HPF IgG4+ and IgG4+/IgG+ ratio > 40% in an average of 
3 HPFs, as described elsewhere[4]. 
Table 1
Clinico-Pathological Data f 23 Cases f IFP
Case Gender/ Size Anatomic Histologic pattern Eosinophils Plasmacells Lymphocytes Fibroblastic Storiform pattern
Other 
features
N# Age (mm) Site Sec.Kim et al.(8) Proliferation
1 F/76 10 stomach fibrovascular numerous moderate moderate marked yes+focal perivasc. fibrosis
2 M/75 3 stomach nodular numerous moderate moderate marked no
3 F/64 23 stomach fibrovascular numerous moderate moderate marked yes+perivascular fibrosis
4 F/57 7 stomach fibrovascular numerous moderate moderate° marked yes
5 M/64 16 ileum sclerotic numerous few few marked no
6 M/67 35 ileum sclerotic moderate moderate moderate mild no
7 F/46 23 stomach sclerotic numerous moderate moderate° marked yes+focal perivase.fibrosis
8 F/83 20 stomach fibrovascular numerous moderate moderate° marked yes+perivasc.fibrosis
9 F/53 10 stomach fibrovascular numerous moderate moderate° marked yes+focal perivasc.fibr
10 M/45 7 stomach fibrovascular numerous few few marked yes
11 M/52 27 ileum edematous moderate numerous numerous moderate mild+perivascular fibrosis ulceration
12 F/47 23 ileum fibrovascular numerous few few marked yes+focal perivasc.fibrosis
13 F/68 8 stomach sclerotic numerous moderate few mild no ulceration
14 F/58 25 large bowel edematous numerous moderate moderate° marked no ulceration
15 F/72 30 ileum edematous numerous few few marked no ulceration
16 F/81 23 ileum fibrovascular rare rare rare marked yes floret cells
17 M/74 8 stomach nodular unmerous numerous numerous marked mild+perivascular fibrosis
18 F/40 20 large bowel fibrovascular numerous numerous numerous marked yes+perivasc.flbrosis
19 M/73 15 stomach fibrovascular numerous numerous numerous marked yes+perivase.fibrosis
20 F/44 5 stomach fibrovascular numerous moderate moderate marked yes
21* F/72 30 stomach fibrovascular numerous moderate moderate marked yes+perivase.fibrosis floret cells
22 F/83 20 stomach edematous numerous moderate moderate° moderate yes+perivase.fibrosis
23 F/65 15 stomach edematous numerous moderate moderate° marked no
Note. °with lymphoid follicles, *case fulfilling criteria sec.Cheuk and Chan(5).
RESULTS
One case of IFP out of 23 (4.3%) fulfilled the IgG4-
RSD histological criteria. Two other cases showed a 
slightly increased number of IgG4+ plasma cells. Most 
cases displayed rare IgG4+ plasma cells, usually in a 
background of few IgG+ plasma cells. In the case with 
increased IgG4+ plasma cells, both IgG+ and IgG4+ 
plasma cells were concentrated in the stroma of the polyp, 
whereas very few IgA+ plasma cells were observed (Figure 
1). From the histological point of view, the cases with 
significant or slightly increased number of IgG4+ plasma 
cells did not differ from the others. The patient presenting 
IFP with significantly increased IgG4 expression did not 
show elevated serological level of IgG4, nor other signs 
of IgG4-RSD.
DISCUSSION
Few cases of inflammatory conditions and tumors, 
characterized by significant number of IgG4+ plasma 
cells, have been reported in GI tract, raising the possibility 
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of an IgG4-RSD. Two cases reported in the esophagus, 
presented as esophagitis with stricture. In one patient 
a raised IgG4 serum level was also found; none of the 
patients presented other signs of IgG4-RSD[6-7]. Gastric 
involvement has been reported as thickening and 
multinodularity of mucosa[8], or multiple polyps [9]; in both 
cases the patients presented also autoimmune pancreatitis 
(AIP). Few other cases presenting as pseudotumors 
were described showing high number of IGg4+ plasma 
cells, but none of the patients had elevated serum level 
of IgG4 nor other IgG4-RSD[10-13]. Two cases of gastric 
ulcer were reported, one of the patients presenting a 
raised serum level of IgG4, but no other IgG4-related 
manifestations[14-15]. An IgG4-related pseudotumor has 
been described in major duodenal papilla[16], and in the 
ileal conduit after surgery for urinary bladder cancer[17], 
again not associated to other IgG4-RSD. A solitary 
jejunal ulcer has been described as an IgG4-RSD, in a 
patient presenting also a raised serum level of IgG4[18]. 
Involvement of colon by IgG4+ plasma cells has been 
reported in a polyposis of a patient suffering from AIP[19]; 
two other cases of colonic IgG-4 fibrosclerosing nodular 
lesions appeared not related to other IgG4-RSD[12]. 
Recently, a significant increase of IgG4 positive plasma 
cells has also been observed in the colonic polyp of a 
patient with Cronkhite-Canada syndrome[20]. 
It is well known that different types of inflammatory 
lesions in the gastrointestinal tract, such as Inflammatory 
Bowel Disease, can present increased, but not significant, 
number of IgG4+ plasma cells[21]. Based on the most 
recent consensus, a diagnosis of IgG4-RSD should 
comprehend histopathological criteria, elevated serum 
lNote.evel of IgG4, involvement of other organs, and 
response to steroid therapy[5]. 
The finding of a clinically relevant mass with abundant 
IgG4+ plasmacellular infiltrate has been proposed as the 
minimum criterion  to make a diagnosis of IgG4-related 
GI disease[22]. The observation of a significant number of 
IgG4 positive plasma cells fulfilling the criteria for IgG4-
RSD in only one case of our series of 23 IFP’s, suggests 
that an IgG4-related pathogenesis for this lesion is 
unlikely. Nevertheless, rare cases showing a high content 
of IgG4 positive plasma cells can be encountered. In such 
cases, steroid therapy could be reasonably offered[22], thus 
avoiding surgical treatment. Interestingly, an ampullary 
pseudotumor resulted cured after steroid therapy for 
AIP[23], whereas cases of  IFP in patients suffering from 
Helicobacter Pylori infection were reduced in volume by 
treating the patients with eradication therapy[24-25]. 
In conclusion, the histological entity currently called 
IFP is not only characterized by genetic mutations, as 
observed in a large percentage of cases[2], but few cases 
could be also related to infections or immunological 
processes, suggesting different therapeutic approaches. 
More cases should be studied to detect the real incidence 
and significance of IgG4 expression in IFP. 
Figure 1
A Case of IFP of the Stomach (a), Showing Few IgA+ Plasma Cells (b), and a High Number of IgG+ (c) and 
IgG4+ Plasma Cells (d)
Copyright © Canadian Research & Development Center of Sciences and Cultures
4
Inflammatory Fibroid Polyps of Gastrointestinal Tract Rarely Show 
Increased IgG4 Expression
REFERENCES
[1] Vanek, J. (1949). Gastric submucosal granuloma with 
eosinophilic infiltration. Am J Pathol,  25, 397-411.
[2] Huss, S., Wardelmann, E., & Goltz, D., et al. (2012). 
Activating PDGFRA mutations in inflammatory fibroid 
polyps occur in exons 12, 14 and 18 and are associated with 
tumour localization. Histopathology, 61, 59-68.
[3] Liu, T.-C., Lin, M.-T., Montgomery, E. A., & Singhi, 
A. D. (2013).  Inflammatory fibroid polyps of the 
gastrointestinal tract. Spectrum of clinical, morphologic, 
and immunohistochemistry features. Am J Surg Pathol,  37, 
586-592.
[4] Cheuk, W., Chan, J. K. (2010). IgG4-related sclerosing 
disease: A critical appraisal of an evolving clinicopathologic 
entity. Adv Anat Pathol, 17, 303-332.
[5] Deshpande, V., Zen, Y., & Chan, J. K., et al. (2012). 
Consensus statement on the pathology of IgG4-realetd 
disease. Mod Pathol , 25, 1181-1192.
[6] Lopes, J., Hochwald, S. N., Lancia, N., Dixon, L. R., & 
Ben-David, K. (2010). Autoimmune esophagitis: IgG4-
related tumors of the esophagus. J Gastrointest Surg, 14, 
1031-1034.
[7] Lee, H., Joo, M., Song, T. J, Chang, S. H., Kim, H., 
Kim, Y. S., & Ryoo, J. Y. (2011). IgG4-related sclerosing 
esophagitis: a case report. Gastrointest Endosc, 73, 834-
       837.
[8] Baez, J. C., Hamilton, M. J., Bellizzi, A., & Mortelé, K. J. 
(2010). Gastric involvement in autoimmune pancreatitis: 
MDCT and histopathologic features. JOP, 11, 610-613.
[9] Kaji, R., Okabe, Y., & Ishida, Y., et al. (2010). Autoimmune 
pancreatitis presenting with IgG4-positive multiple gastric 
polyps. Gastrointest Endosc, 71, 420-422.
[10] Kim, do H., Kim, J.,&  Park, do H., et al. (2012). 
Immunoglobulin G4-related inflammatory pseudotumor of 
the stomach. Gastrointest Endosc , 76, 451-452.
[11] Rollins, K. E., Mehta, S. P., O’Donovan, M., & Safranek, P. 
M. (2011). Gastric IgG4-related autoimmune fibrosclerosing 
pseudotumour: A Novel Location. ISNR Gastroenterol 
873087.
[12] Chetty, R., Serra, S., Gauchotte, G., Maerkl, B., & Agaimy, 
A. (2011). Sclerosing nodular lesions of the gastrointestinal 
tract containing large number of IgG4 plasma cells. 
Pathology, 43, 31-35.
[13] Na, K. Y., Sung, J. Y., Jang, J. Y., Lim, S. J, Kim, G.Y., Park, 
Y. K., & Lee, J. H. (2012). Gastric nodular lesions caused 
by IgG4-related disease. Pathol Int , 62, 716-718.
[14] Fujita, T., Ando, T., Sakakibara, M., Hosoda, W., & Goto, 
H. (2010). Refractory gastric ulcer with abundant IgG4-
positive plasma cell infiltration: A case report. World J 
Gastroeneterol, 16, 2183-2186.
[15] Bateman, A. C., Sommerlad, M., & Underwood, T. J. (2012). 
Chronic gastric ulceration: a novel manifestation of IgG4-
related disease? J Clin Pathol, 65, 569-570.
[16] Hisa, T., Ohkubo, H., Shiozwa, S., Ishigame, H., Furutake, 
M., & Takamatsu, M. (2008). Lymphoplasmacytic 
granuloma localized to the ampulla of Vater: An ampullary 
lesion of IgG4-related systemic disease? Gastroenterol 
Endosc, 68, 1229-1232.
[17] Kuroda, Y., Fujioka, M., Kurosawa, K., & Ohashi, K. (2011). 
IgG4-related inflammatory pseudotumor of the ileal conduit. 
Pathol Int, 61, 47-48.
[18] Wong, D. D., Pillai, S. R., & Priyanthi, K. M., et al. 
(2012). IgG4-related sclerosing disease of the small bowel 
presenting as necrotizing mesenteric arteritis and a solitary 
jejunal ulcer. Am J Surg Pathol,  36, 929-934.
[19] Matsui, H., Watanabe, T., & Ueno, K., et al. (2009). 
Colonic polyposis associated with autoimmune pancreatitis. 
Pancreas, 38, 840-842.
[20] Bettington, M., Brown, I. S., Kumarasinghe, M. P.,  de Boer, 
B., Bettington, A., &  Rosty, C. (2014). The challenging 
diagnosis of cronkhite-Canada syndrome in the upper 
gastrointestinal tract: A series of 7 cases with clinical 
follow-up. Am J Surg  Pathol, 38, 215-23.
[21] Strehl, J. D., Hartmann, A., & Agaimy, A. (2011). Numerous 
IgG4-positive plasma cells are ubiquitous in diverse 
localised non-specific chronic inflammatory conditions 
and need to be distinguished from IgG4-related systemic 
disorders. J Clin Pathol,  64, 237-243.
[22] Koizumi, S., Kamisawa, T., & Kumura, S., et al. (2013). 
Immunoglobulin G4-related gastrointestinal diseases, 
are they immunoglobulin G4-related diseases? World J 
Gastroenterol, 19, 5769-5774.
[23] Kamisawa,  T. ,  Anj ik i ,  H. ,  & Egawa,  N.  (2010) . 
Disappearence of an ampullary pseudotumor after steroid 
therapy for autoimmune pancreatitis. Gastrointest Endosc, 
71, 110-114.
[24] Nishiyama, Y., Koyama, S., & Andoh, A., et al. (2003). 
Gastric inflammatory fibroid polyp treated with helicobacter 
pylori eradication therapy. Intern Med., 42, 263-267.
[25] Hirasaki, S., Matsubara, M., & Ikeda, F., et al. (2007). 
Gastric inflammatory fibroid polyp treated with Helicobacter 
pylori eradication therapy. Intern Med, 46, 855-858.
